· .. and diabetes may not be a contraindication to beta blocker therapy

In a survey of secondary prophylactic therapy after myocardial infarction by Eccles. et al. [see Inphanna 770: 9, 19 Jan 1991], diabetes mellitus was one of the contraindications to beta blocker therapy. However. 2 recent retrospective studies have stated that these agents may be beneficial in such patients [see Inpharma 696: 10, 22 Jul 1989 and 1npharma 729: 12, 24 Mar 1990]. As it is unlikely that an appropriate prospective, randomised trial in patients with diabetes will be undertaken in the near future, ' ... I suggest that we do not regard diabetes as a contraindication to the use of f3 bloclurs after myocardial infarction'.

Nicol P. Secondary prophylaxis against myocardial infarction. British Medical Journal 302: 657, 16 Mar 1991 [Summarised from a letter to the Editor] 5910

ISSN 0156-2703/91/0330-0003/0$01.00/0 © Adu I"tentlltio"a/ Ltd

3 INPHARMA@30 Mar 1991 _